{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_052997.4:c.5746A>T",
          "cDNA Change": {
            "transcript": "NM_052997.4",
            "ref": "A",
            "alt": "T",
            "position": "5746"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "1915"
          },
          "Description in input context": "I1915T (pathogenic mutation in LRRK2)"
        },
        {
          "HGVS": "NM_052997.4:c.5812G>A",
          "cDNA Change": {
            "transcript": "NM_052997.4",
            "ref": "G",
            "alt": "A",
            "position": "5812"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "1937"
          },
          "Description in input context": "G2019S (pathogenic mutation in LRRK2)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005222"
  },
  "Experiment Method": [
    {
      "Assay Method": "Reporter gene assay (EGFP with let-7-binding sites)",
      "Material used": {
        "Material Source": "Drosophila and human cells",
        "Material Name": "Drosophila and human cell lines",
        "Description": "EGFP reporter constructs with let-7-binding sites were used in Drosophila and human cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_052997.4:c.5746A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Pathogenic I1915T and G2019S variants increased EGFP reporter expression compared to wild-type controls."
        },
        {
          "Variant": "NM_052997.4:c.5812G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Pathogenic G2019S variant increased EGFP reporter expression compared to wild-type controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-pathogenic variants were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "EGFP expression level comparable to wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "EGFP expression level significantly higher than wild-type controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "RNAi knockdown and kinase activity assays",
      "Material used": {
        "Material Source": "Cell line and Drosophila models",
        "Material Name": "Drosophila and human cell lines",
        "Description": "RNAi was used to knock down LRRK2 or Argonaute proteins in cell lines and Drosophila models."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_052997.4:c.5746A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "RNAi knockdown of LRRK2 or Argonaute proteins reduced the effect of I1915T and G2019S variants."
        },
        {
          "Variant": "NM_052997.4:c.5812G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "RNAi knockdown of LRRK2 or Argonaute proteins reduced the effect of G2019S variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-pathogenic variants were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein activity comparable to wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein activity significantly altered compared to wild-type controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}